microRNA-34a as a Therapeutic Agent against Human Cancer.
about
Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkersResistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators.Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review).Drug Delivery via Cell Membrane Fusion Using Lipopeptide Modified Liposomes.miR-592/WSB1/HIF-1α axis inhibits glycolytic metabolism to decrease hepatocellular carcinoma growth.Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism.Inflammation and epigenetic regulation in osteoarthritis.MicroRNA-34a: A Versatile Regulator of Myriads of Targets in Different Cancers.Simultaneous overexpression of miR-126 and miR-34a induces a superior antitumor efficacy in pancreatic adenocarcinoma.miR-34a expression in human breast cancer is associated with drug resistance.Elevated microRNA-34a contributes to trophoblast cell apoptosis in preeclampsia by targeting BCL-2.Silencing of Long Non-coding RNA MIAT Sensitizes Lung Cancer Cells to Gefitinib by Epigenetically Regulating miR-34a.Altered expression of apoptosis-regulating miRNAs in salivary gland tumors suggests their involvement in salivary gland tumorigenesis.In bone metastasis miR-34a-5p absence inversely correlates with Met expression, while Met oncogene is unaffected by miR-34a-5p in non-metastatic and metastatic breast carcinomas.New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma.Total RNA extraction from tissues for microRNA and target gene expression analysis: not all kits are created equal.Expression of miR-34a in T-Cells Infected by Human T-Lymphotropic Virus 1.Expression of miR-146a-5p in breast cancer and its role in proliferation of breast cancer cells.Modulation of intracellular calcium signaling by microRNA-34a-5p
P2860
Q29248723-6F555BD2-4283-4D85-9D78-295032129FDAQ33850064-CBC3EE77-D348-4011-82F2-046F7A69B2FEQ36992190-F30B4A84-80D0-4346-8E97-775EAB1B5677Q37299036-C8072A8A-27A3-4AAE-8374-F164BB015C2AQ37376524-CDAF42B2-6C28-45A6-89E9-205037E863E8Q37591581-89C252AC-F807-40D0-9E71-A3BFB73F0F69Q37606976-25FB035B-A0F4-4172-88D7-24B37EEA5BE9Q44463289-7058A73E-EB9D-4DC2-AF25-943DD8A3DDC2Q47122468-54C2C84A-946B-49F5-BE46-3E74BD803C5DQ47139724-6589DD96-845C-44EB-823B-FF3718915087Q47664125-D183F0A6-EDA7-40EE-BEDD-D2CC9E712008Q50318108-6652C1B8-7917-4E2A-8A13-D19ECF33E429Q51008399-F17A32CF-FBB8-4502-B39C-960E52B509C3Q51089746-08D35959-77D8-4166-8848-D32175E5ACC8Q52581757-902725E1-E385-472A-BE78-F282DA9835B2Q53275343-10D55D50-F56D-428E-B5B1-B481335971DCQ54205015-56315497-6E14-43DA-8B37-96268AC59667Q55428154-1836A42C-2DC0-4C59-B5A0-612EA8CFEFCEQ57148008-7ED47744-2626-47AD-85CD-A9FF7E2E207D
P2860
microRNA-34a as a Therapeutic Agent against Human Cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
microRNA-34a as a Therapeutic Agent against Human Cancer.
@en
type
label
microRNA-34a as a Therapeutic Agent against Human Cancer.
@en
prefLabel
microRNA-34a as a Therapeutic Agent against Human Cancer.
@en
P2093
P2860
P356
P1476
microRNA-34a as a Therapeutic Agent against Human Cancer.
@en
P2093
Hidetsugu Saito
Toshiaki Nakaoka
Yoshimasa Saito
P2860
P304
P356
10.3390/JCM4111951
P577
2015-11-16T00:00:00Z